Steigerwald Gordon & Koch’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $277K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $242K | Hold |
|
|||||
|
2021
Q3 | $218K | Hold |
|
|||||
|
2021
Q2 | $205K | Hold |
|
|||||
|
2021
Q1 | $239K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $213K | Hold |
|
|||||
|
2018
Q3 | $430K | Hold |
|
|||||
|
2018
Q2 | $324K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $214K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $202K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $204K | Hold |
|
|||||
|
2016
Q2 | $238K | Hold |
|
|||||
|
2016
Q1 | $214K | Hold |
|
|||||
|
2015
Q4 | $217K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $328K | Buy |
|